AAPG Stock Analysis: Buy, Sell, or Hold?
AAPG - Ascentage Pharma Group International American Depository Shares
$24.18
-0.82 (-3.28%)
▼
5d:
-7.71%
30d:
-6.71%
90d:
-29.83%
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 26, 2026
Get Alerted When AAPG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AAPG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AAPG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AAPG is currently trading at $24.18, which is considered oversold relative to its 30-day fair value range of $25.53 to $27.87.
Technical Outlook: Technically, AAPG is in a strong downtrend. The price is currently testing key support at $24.18. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: AAPG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $45.71 (+89.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AAPG is in a strong downtrend. The price is currently testing key support at $24.18. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: AAPG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $45.71 (+89.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$25.53 -
$27.87
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 89.1% below Wall St target ($45.71)
- CAUTION: 5-day price weakness (-7.7%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$25.53 -
$27.87
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$24.18
Resistance Level
$28.23
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-50.30
Wall Street Target
$45.71
(+89.1%)
Revenue Growth (YoY)
-71.6%
Profit Margin
-296.8%
Last updated: February 02, 2026 5:10 AM ET
Data refreshes hourly during market hours. Next update: 6:10 AM
Data refreshes hourly during market hours. Next update: 6:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AAPG showing a specific setup today?
Featured in Portfolios
AAPG is a key holding in these high-performance investment strategies.
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 55 HOLD |
